TCL Archive FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions. June 2, 2006
TCL Archive High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I April 27, 2001
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013